Specialized pharmaceutical manufacturer Jeronselvain announced on the 14th that it will officially target domestic and overseas markets by launching the PDRN ingredient product ‘Cellvane Skin Booster’.
Jeronselvain’s ‘Cellvane Skin Booster’ is based on polynucleotide (PDRN) and is highly effective in skin improvement, including skin regeneration, wrinkle reduction, skin elasticity and texture enhancement, and skin tone whitening.
In particular, as the Ministry of Food and Drug Safety has banned the use of exosomes in skin boosters starting this year, PDRN skin boosters are expected to replace the exosome market in the future.
This product applies Cellvane’s proprietary patented Prism Technology (Prism-T), offering not only safety but also excellent efficacy due to high absorption rates. Using PDRN pharmaceutical base ingredients approved as prescription drugs, it is highly effective in restoring the skin barrier and promoting cell regeneration.
Jeronselvain explained that after the launch of ‘Cellvane Skin Booster,’ inquiries for overseas exports, Original Design Manufacturing (ODM), and Original Equipment Manufacturing (OEM) have been pouring in.
Kim Deok-gyu, CEO of Jeronselvain, said, “The newly launched ‘Cellvane Skin Booster’ is a high-functional skin booster focused on activating the skin’s natural regenerative power,” adding, “It will be an effective choice for consumers seeking skin improvement.”
He continued, “We expect to set a new standard in both domestic and overseas markets with a product of global high quality,” and added, “We will actively leverage the product’s strengths to emphasize differentiation mainly through major hospitals and clinics, and will strengthen our position by conducting aggressive marketing and sales activities.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
